EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,716,226 | +10.8% | 170,079 | -3.1% | 0.04% | -7.5% |
| Q2 2023 | $3,352,888 | +806.2% | 175,452 | +643.9% | 0.04% | +400.0% |
| Q3 2022 | $370,000 | -77.8% | 23,584 | -70.6% | 0.01% | -81.8% |
| Q2 2022 | $1,670,000 | +218.7% | 80,217 | +178.7% | 0.04% | +340.0% |
| Q2 2021 | $524,000 | -73.2% | 28,785 | -65.1% | 0.01% | -89.7% |
| Q2 2020 | $1,957,000 | +9.3% | 82,451 | -18.6% | 0.10% | +59.0% |
| Q3 2019 | $1,791,000 | +112.2% | 101,253 | +156.3% | 0.06% | +154.2% |
| Q2 2019 | $844,000 | -55.8% | 39,512 | -54.1% | 0.02% | -61.3% |
| Q1 2018 | $1,908,000 | -6.3% | 86,135 | +28.6% | 0.06% | +19.2% |
| Q4 2017 | $2,037,000 | +22.0% | 67,000 | -2.7% | 0.05% | +20.9% |
| Q3 2017 | $1,669,000 | -36.1% | 68,880 | -35.1% | 0.04% | -46.2% |
| Q2 2017 | $2,613,000 | +575.2% | 106,091 | +308.5% | 0.08% | +700.0% |
| Q4 2016 | $387,000 | -38.7% | 25,973 | -47.4% | 0.01% | -33.3% |
| Q3 2016 | $631,000 | +156.5% | 49,374 | +57.0% | 0.02% | +200.0% |
| Q2 2016 | $246,000 | -3.1% | 31,445 | -50.5% | 0.01% | -16.7% |
| Q1 2016 | $254,000 | +490.7% | 63,482 | +125.1% | 0.01% | +200.0% |
| Q3 2014 | $43,000 | -23.2% | 28,200 | +79.5% | 0.00% | 0.0% |
| Q1 2014 | $56,000 | – | 15,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |